


More Effective Antifibrotic Therapies for Systemic Sclerosis in Development; Adverse Events A Concern

The Immune Checkpoint Inhibitors Unleashed to Fight Cancer

Rheumatology Case Report: Immune-Related Aortitis Associated with Ipilimumab
Adverse Events More Common with Off-Label Drug Use

Tofacitinib on Hold for Psoriasis, Plus Anti-TNFs Top FDA List for Adverse Events

FDA Issues Stronger Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Warning
